Durable Clinical Benefit With Nivolumab Plus Ipilimumab in DNA Mismatch Repair-Deficient/Microsatellite Instability-High Metastatic Colorectal Cancer. Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology, JCO2017769901. https://doi.org/10.1200/JCO.2017.76.9901 (Original work published 2018)
. (2018).